Kevin Houlihan

Kevin is responsible for regulatory functions in support of the approval and maintenance of sterile injectable and topical drug products. He acts as a main contact with manufacturers, contract labs, graphic artists and translators in order to compile and file electronic drug submissions with Health Canada. He also works to maintain current product labelling.

Kevin brings prior Regulatory Affairs experience from the Pharmaceutical industry, joining Teligent (formerly Alveda) from Lambda Therapeutic Research Inc. where he functioned as a Regulatory Affairs Associate.

Kevin has earned his Honours Bachelor of Science degree from Queen’s University in Chemistry and his post-graduate diploma from Seneca College in Pharmaceutical Regulatory Affairs and Quality Operations, and works out of our Canadian office in Toronto, Ontario.